EEU - pharmacokinetic equation??? [Power / Sample Size]

posted by mittyri – Russia, 2017-12-29 15:11 (2253 d 08:25 ago) – Posting: # 18126
Views: 32,454

Hi Yura,

❝ So I understand: imagine the power analysis and draw a conclusion (at low power) that since bioequivalence is established, a posteriori power rating does not affect the findings of the study

Yep. Once again: to be lucky is not a crime :-D
and vice versa: if the post-hoc power is -> 100%, you're a hero even if the study was overpowered de facto (i.e. CI [0.98-1.03]).

❝ More interesting question: the pharmacokinetic equation and its analysis ... :confused:

Good question! Next question!
Seems like they are interested in PK model which is not permitted. No clue so far :-|

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,916 posts in 4,807 threads, 1,646 registered users;
42 visitors (0 registered, 42 guests [including 11 identified bots]).
Forum time: 23:36 CET (Europe/Vienna)

Nothing shocks me. I’m a scientist.    Harrison Ford (as Indiana Jones)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5